A share price increase of nearly 60.85% was observed at MedMen Enterprises Inc. from its previous close to reaching $0.272. A total of 517,354,427 shares of the company are outstanding, and its Market Capitalization is 140,720,404 at its current price.
MEDMEN line of Operation
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
A cannabis retailer with flagships in California, Nevada, Illinois, Florida, and New York, MedMen offers cannabis in a wide range of strains. With its premium retail stores, proprietary delivery service, as well as curbside and in-store pick-up options, MedMen offers a robust selection of high-quality products. These include MedMen-owned brands like [statemade], LuxLyte, and MedMen Red. Its loyalty program, MedMen Buds, offers the company exclusive access to its promos, product drop, and content. The MedMen movement strongly believes that legalizing and regulating cannabis is safer, healthier, and happier for all.
What’s the latest news
The stock market will learn of the financial results of MedMen Enterprises Inc.’s second-quarter fiscal 2021 ending December 26, 2020, after market close on February 16, 2021.
To discuss the results in further detail, MedMen will host a conference call and audio webcast with Chief Executive Officer Tom Lynch; Chief Financial Officer Reece Fulgham; and Chief Operating Officer Tim Bossidy.
On the Events and Presentations section of MedMen’s website, you can listen to a live audio webcast of the call throughhttps://investors.medmen.com/events-and-presentations/default.aspx and will be archived for replay.
Toll Free Dial-In Number: (844) 559-7829
International Dial-In Number: (647) 689-5387
Conference ID: 4282344